bpc-157 amino acids Peptide Therapy BPC-157 – Mark Hyman, MD

The mg-to-mcg conversion trips up researchers frequently

and J.T.A

Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model

WADA prohibited substance BPC-157 has been on the World Anti-Doping Agency Prohibited List under category S0 (non-approved substances) since 2022 and remains on the 2025 list

BPC-157 is a short, highly stable, 15-amino-acid pentadecapeptide, in contrast to fragile, high molecular weight growth factors, like Insulin-like Growth Factor 1 (IGF-1) or Fibroblast Growth Factor (FGF)

And almost all of them are sourcing it from sketchy online vendors, many of which are supplied by manufacturers in China